Stay updated on Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.

Latest updates to the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1, indicating a new version release. The removal of 'Back to Top' is a minor UI change with no impact on core content.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical topics related to colorectal cancer and various proteins. Notably, several previous terms related to antineoplastic agents and immune checkpoint inhibitors have been removed.SummaryDifference1%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check44 days agoChange DetectedThe web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.4%
Stay in the know with updates to Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.